大鼠体内复方清开灵代谢物的分析

建立了复方中药清开灵代谢物的液相色谱-质谱/质谱分析方法。采用Phenomenex Luna C18色谱柱,以0.1%甲酸(A)及V(甲醇)∶和V(乙腈)=4∶1混合液(B)作流动相,采用梯度洗脱(0 min,B为0%;33min,B为60%;66 min,B为88%;75 min,B为100%),流速:0.5 mL/min,离子阱质谱负离子模式进行检测。通过差谱方法对可能的代谢物进行快速搜索。对发现的重要的代谢物根据分子量以及多级质谱的碎片离子数据,结合体内代谢反应规律,进行指认和结构鉴定。共鉴定了3个主要的代谢物,其中一个为黄芩苷的代谢物,另两个为绿原酸的代谢物,后两个代谢物未见文献报道。本实验为研究复方中药复杂体系体内的代谢产物提供了一个有效而且快捷的模式。     

高效毛细管电泳法分析蓝色签字笔字迹色痕种类及相对形成时间

选用毛细管区带电泳分离模式,对13种市售蓝色签字笔样品字迹色痕进行了分析。当电压为15 kV、柱温为25 ℃时,以0.03 mol/L 四硼酸钠水溶液(外加10%(体积分数)的甲醇)为缓冲液,所有样品都可以得到良好的区分;依据紫外区检测结果,样品可以分为三大类、五小类;依据可见区检测结果,样品可以分为四类;两种分析结果相结合有助于增大不同样品之间的区分度;选择3种样品进行暗处保存老化制样,根据字迹中色料成分相对含量的变化,对字迹的相对形成时间进行了初步探讨。研究还发现纸张类型对于上述研究结果无影响。     

土壤重金属污染来源及其解析研究进展

土壤重金属污染问题是环境和土壤科学研究者关注的热点问题。对土壤重金属污染物来源的鉴别是准确、有效控制和治理污染源的前提。根据近年来国内外对土壤重金属污染的相关研究报道,综述了土壤中污染物的工业、农业和交通因子三大主要来源,重点阐述了目前解析土壤重金属污染来源所运用的化学形态研究、剖面分布、同位素示踪、空间分析和多元统计等方法,并就存在的问题和今后的研究重点进行了总结。     

氢化诺卜醇及其烷基醚的合成与表征

由β-蒎烯与多聚甲醛反应制得诺卜醇,然后用Ni(R)催化氢化制得氢化诺卜醇(ROH),再将氢化诺卜醇与亚硫酰氯反应制得氢化诺卜基氯(RCl),由RCl分别与6种醇钠反应合成了6种氢化诺卜基烷基醚,各产物的得率均在92%以上,GC纯度95%以上。各产物都用IR,1H NMR,13C NMR与MS进行了结构表征。     

SPME/GC-MS鉴别地沟油新方法(Ⅱ)

采用固相微萃取/气相色谱-质谱(SPME/GC-MS)方法测定地沟油中的微量杂质成分,通过对各种纯正植物油中的内源性微量成分与不同地区地沟油中的外源性杂质成分的对比分析,以及对地沟油中杂质成分来源的分析,确定了广州、贵州、深圳、北京等地区地沟油的特征成分,并作为鉴别指示成分。该方法灵敏度高、特征性强,在卫生部组织的地沟油检测盲样考核中,对阳性样品判断的准确率高达95.5%。     

Ultra‐performance liquid chromatography coupled with electrospray ionization/quadrupole time‐of‐flight mass spectrometry for the rapid analysis of constituents in the traditional Chinese medical formula Danggui San

In this work, ultra‐performance LC with ESI quadrupole TOF‐MS (UPLC–ESI‐Q‐TOF‐MS) and automated MetaboLynx analysis was used to rapidly separate and identify the chemical constituents of Danggui San, a traditional Chinese medical formula. The analysis was performed on a Waters UPLC BEH C₁₈ column using a gradient elution system. A hyphenated ESI and Q‐TOF analyzer was used for the determination of the accurate mass of the protonated or deprotonated molecule and fragment ions in both positive and negative modes. Based on retention times, accurate mass, and the mass spectrometric fragmentation characteristics, a total of 47 compounds distributed over the chemical groups of phthalides, flavonoids, monoterpene glycosides, sesquiterpenoids, phenolics, and alkaloids, were simultaneously separated within 18 min and identified or tentatively elucidated in Danggui San for the first time. UPLC–ESI‐Q‐TOF‐MS analysis revealed the complexity of the chemical composition of this formula. The method developed is rapid, accurate, reliable, and highly sensitive to characterize the chemical constituents of Danggui San.     

Isolation and identification of nondestructive desulfurization bacterium

A nondestructive desulfurization microorganism has been isolated. The metabolism product analyses show that the strain can be a kind of biocatalyst to oxidize dibenzothiophene (DBT) into 2-hydroxydiphenyl (HBP), therefore the sulfur in DBT is removed selectively. The 16SrRNA information, cell wall analysis, physical, biochemical properties and morphological properties suggest that the isolated strain is Rhodococcus erythropolis. The strain can grow in the basal salts medium (BSM) that DBT concentration is no more than 10 mmol/L, and the optimal DBT concentration for growth is 1 mmol/L, however, the optimal DBT concentration for desulfurization is 0.5 mmol/L. The further research shows that the strain can also desulfur some other or-ganosulfur-containing compounds such as thianaphthene, phenyl sulfide and 4,6-dimethyldiben-zothiophene (4,6-DMDBT).     

外泌体分离与纯化技术研究进展

外泌体是所有真核细胞分泌到细胞外的直径介于30～150 nm的一种膜性纳米囊泡,参与细胞间生物信号的传递。大量实验证据表明,外泌体参与多种生物功能并发挥重要作用,包括蛋白质、RNA和脂质等生物分子的转移及多种疾病生理和病理过程的调节,被认为是疾病诊断、治疗和预后的重要的生物标志物和药物载体,因此发展简单、高效、经济的外泌体分离与纯化技术将有助于疾病的早期诊断和精准治疗。目前,利用外泌体的物理化学和生物化学特性已开发出多种分离外泌体的技术,但仍缺乏标准化和规模化临床级外泌体的分离方法,从而限制了其临床应用。另外,对分离出的外泌体的特征、纯度和数量的鉴定是判断外泌体分离纯化方法优劣的重要指标。本文综述了外泌体分离与纯化技术以及鉴定方法的研究进展,主要讨论分离技术的机制、性能、挑战和前景以及外泌体的鉴定方法,以期为外泌体的分离纯化提供新的思路和解决策略。     

Large scale synthesis of red emissive carbon dots powder by solid state reaction for fingerprint identification

Red emissive carbon dots(CDs) powder was synthesized on a large scale from phloroglucinol and boric acid by a novel solid state reaction with yield up to 75%. This method is safe and convenient, for it needs neither high pressure reactors nor complicated post-treatment procedures. The as-prepared carbon dots powder exhibited strong red fluorescence with excitation-independent behavior. XPS measurement and PL spectra suggest that such red fluorescence arise from boron-doped structures in CDs, which increases along with the boron concentration on CDs surface but decreases when the concentration quenching effect takes place. To overcome the aggregation induced fluorescence quenching of the solid CDs powder,the conventional methods are dispersing CDs into a large amount of inert substrates. But our present work provides a new strategy to realize strong red fluorescence of CDs in solid state. As a result, such carbon dots powder works well for latent fingerprint identification on various material surfaces.     

Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid

Duchenne muscular dystrophy (DMD) is a fatal muscle‐wasting disease arising from mutations in the dystrophin gene. Upregulation of utrophin to compensate for the missing dystrophin offers a potential therapy independent of patient genotype. The first‐in‐class utrophin modulator ezutromid/SMT C1100 was developed from a phenotypic screen through to a Phase 2 clinical trial. Promising efficacy and evidence of target engagement was observed in DMD patients after 24 weeks of treatment, however trial endpoints were not met after 48 weeks. The objective of this study was to understand the mechanism of action of ezutromid which could explain the lack of sustained efficacy and help development of new generations of utrophin modulators. Using chemical proteomics and phenotypic profiling we show that the aryl hydrocarbon receptor (AhR) is a target of ezutromid. Several lines of evidence demonstrate that ezutromid binds AhR with an apparent K_D of 50 nm  and behaves as an AhR antagonist. Furthermore, other reported AhR antagonists also upregulate utrophin, showing that this pathway, which is currently being explored in other clinical applications including oncology and rheumatoid arthritis, could also be exploited in future DMD therapies.